Crossmark

Clinical outcomes comparison of 10 years versus 5 years of adjuvant endocrine therapy in patients with early breast cancer

Crossref DOI link: https://doi.org/10.1186/s12885-018-4878-4

Published Online: 2018-10-12

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Li, Li

Chang, Bingmei

Jiang, Xiaoyue

Fan, Xueke

Li, Yingrui

Li, Teng

Wu, Shanshan

Zhang, Jun

Kariminia, Seyed

Li, Qin http://orcid.org/0000-0002-2470-6089
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81301912)

Beijing Municipal Health System High-level Health Person Foundation Project (2014-3-005)

the Beijing Municipal Science and Technology Commission Foundation (Z161100000516083)

Natural Science Foundation of Capital Medical University
License Information

Text and Data Mining valid from 2018-10-12
More Information

Article History

Received: 14 May 2018

Accepted: 1 October 2018

First Online: 12 October 2018

Ethics approval and consent to participate

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.